China’s Sunshine Lake Pharma Secures Historic FDA Approval for Insulin
Sunshine Lake Pharma becomes first Chinese firm to get FDA green light for a long‑acting insulin, shaking up the $400B US market.
insulin market
🌍NewspaperAmigo – Your Global News Buddy 🗞️
Timely Reports, Friendly Voices – Your Daily News Amigo